Orin Hirschman 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-27 08:08 am Sale | 2022-10-26 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Orin Hirschman | 0 0.000% | -2 (Position Closed) | Filing |
| 2022-02-11 3:06 pm Unchanged | 2021-12-31 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Orin Hirschman | 2 9.900% | 0 (Unchanged) | Filing |